When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department.


Size: 1417px × 1412px
Photo credit: © David Wa / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: &, 19cbdst, 2019, 2019cbdst, acid, acquisition, administration, advanced, agency, agency’, analysis, army, authority, authorization, bacteria, barda, bioinformatics, biological, biomedical, biosurveillance, biothreat, biowarfare, call, cb, cb/jsto, cbd, cbdp, cbds&, cboa, center, chem/bio, chemical, chemistry, command, conference, countermeasures, cwmd, defense, delivery, department, detection, development, disease, dna, dna-based, dod, donavax, drug, dtra, dtra-cb, dtra/scc-wmd, dtracb, ebola, ecbc, ecosystem, edgewood, emergency, empowering, engineering, evd, expertise, fda, food, genomics, laboratory, math, naval, nucleic, operational, papers, program, reduction, research, science, sudan, sustainment, tech, technologies, technology, threat, vaccines, virus